Țară: Spania
Limbă: engleză
Sursă: HMA (Heads of Medicines Agencies)
Amoxicillin as amoxicillin tilhydrate 40 mg, clavulanic acid 10 mg
Norbrook Laboratories Limited
QJ01CR02
Tablet
amoxicillin and enzyme inhibitor
Dogs Non Food
2011-11-24
Revised: November 2011 AN: 01186/2011 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Combisyn 250 mg Tablets for Dogs (RMS UK) Clavobay 250 mg Tablets for Dogs (in CMS AT, BE, FR, IS, IT, NL, NO, PT except DK, SE and ES. Clavobay Vet 200 mg/ 50 mg Tablets for Dogs (SE) Clavubay 250mg Tablets for Dogs (ES) Clavobay vet 250mg Tablets for Dogs (DK) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Amoxicillin (as amoxicillin trihydrate) 200 mg Clavulanic acid (as Potassium clavulanate) 50 mg EXCIPIENTS: Carmoisine Lake (E122) 1.225mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet. Round pink biconvex tablet with a score line and 250 embossed on opposing faces. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of the following infections caused by lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid: Skin infections (including superficial and deep pyodermas) caused by susceptible Staphylococci Urinary tract infection caused by susceptible Staphylococci or _Escherichia _ _coli_ Respiratory infections caused by susceptible Staphylococci Revised: November 2011 AN: 01186/2011 Page 2 of 6 Enteritis caused by susceptible _Escherichia coli_ It is recommended to carry out suitable tests for sensitivity testing when initiating the treatment. The t Citiți documentul complet